TCL Archive IOM Committee Will Probe Duke Scandal Together With Other “Omics” Case Studies January 7, 2011
TCL Archive FDA approval of two colon cancer therapies triggers discussion among researchers, clinicians about best treatment and clinical trial designs. CMS reimbursement pending; costs to U.S. of the new drugs could be billions per year, but some predict dramatic increases in survival. March 5, 2004
TCL Archive Also in this 8-page issue: Dana-Farber opens center for advanced cancer science. April 23, 2004
